MND-SMART – new clinical trial launched
MND-Smart is a new generation of clinical trial in which multiple treatments are evaluated simultaneously.
The trial is led by a team of researchers based in Edinburgh and will test potential new treatments for MND as well as looking at whether existing treatments for other conditions could have some benefit.
Typical clinical trials focus on a single drug – patients receiving the active drug are compared with those who receive an inactive substance, known as the placebo. MND-SMART will allow more than one treatment to be tested against a shared placebo group so that patients have a higher likelihood of receiving an active treatment.
People with MND are invited to register interest in the trial at www.mnd-smart.org. The first participants will be seen in Edinburgh with other clinics across the UK joining during 2020.
It’s good news for people with MND and we’re delighted people will be recruited to the trials through MND Association funded care centres.
MND-SMART is supported by the Euan MacDonald Centre, substantial private donations, MND Scotland and the My Name’5 Doddie Foundation.
Please see this short video for more information about the new clinical trial for patients with motor neuron disease launched today: MND SMART https://t.co/sMAvRrdbf1
— Arpan (@DrArpan100) January 15, 2020
MND: The search for new treatments https://t.co/snMaJGmOG5
— BBC News (UK) (@BBCNews) January 15, 2020
We are delighted to confirm that a ground-breaking MND clinical drug trial is launching in Scotland, following a £1.5 million investment from MND Scotland.
— MND Scotland (@MNDScotland) January 15, 2020